Quality performance indicators for oesophageal and gastric cancer: ANZ expert Delphi consensus
ANZ Journal of Surgery · 2024
DOI: 10.1111/ans.19173 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Suheelan Kulasegaran und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, North Shore Hospital, Auckland, New Zealand. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Stomach Neoplasms, Quality Indicators, Health Care, Delphi Technique. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Quality performance indicators for the management of oesophagogastric cancer can be used to objectively measure and compare the performance of individual units and capture key elements of patient care to improve patient outcomes.
Methods
Two systematic reviews were completed to identify evidence‐based quality performance indicators for the surgical management of oesophagogastric cancer. Based on the indicators identified, a two‐round modified Delphi process with invitations was sent to all members of the Australia and Aotearoa New Zealand Gastric and Oesophageal Surgery Association. The expert working group discussed each suggested indicator and either removed, added, or adjusted the list of indicators of oesophagogastric cancer.
Results
The final list of both OG cancer indicators included Specialized Multi‐disciplinary team discussion, Endoscopy documentation, Staging Contrast CT Chest/Abdomen and Pelvis, Neoadjuvant or Adjuvant chemo/radiotherapy administered in accordance with the Local multi‐disciplinary team, Pathological margin clearance (R0 Resection), Lymphadenectomy retrieving 15 or more nodes, Formal review of pathological findings and documentation, Postoperative complications, 30‐day and 90‐day postoperative mortality, clinical surveillance and Specialized Dietetic guidance. Indicators specific to gastric cancer included Preoperative biopsy for pathological diagnosis and Staging Laparoscopy. Indicators specific to oesophageal cancer include positron emission tomography scan if CT negative for metastasis, Perioperative Oesophagectomy Care Pathway, length of stay of 21 days or more, and Unplanned readmission within 30 days.
Conclusions
The results of this study present a core set of indicators for the surgical management of oesophagogastric cancer that can be used to measure quality and compare performance between different units.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, North Shore Hospital, Auckland, New Zealand.
- Department of Surgery, University of Auckland, Auckland, New Zealand.
- Department of Oncology, University of Auckland, Auckland, New Zealand.
- Department of Upper Gastrointestinal Surgery, Bankstown-Lidcombe Hospital, Sydney, New South Wales, Australia.
- School of Medicine, Western Sydney University, Sydney, New South Wales, Australia.
- Department of Upper Gastrointestinal and Soft Tissue Unit, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
ORCID-Profile: Suheelan Kulasegaran, Braden Woodhouse, Yijiao Wang, Bernard Mark Smithers, David Watson, Jonathan Koea
Zitieren
APA
Kulasegaran, S., Woodhouse, B., Wang, Y., Siddaiah-Subramanya, M., Merrett, N., Smithers, B. M., Watson, D., MacCormick, A., Srinivasa, S., & Koea, J. (2024). Quality performance indicators for oesophageal and gastric cancer: ANZ expert Delphi consensus. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19173
Vancouver
Kulasegaran S, Woodhouse B, Wang Y, Siddaiah-Subramanya M, Merrett N, Smithers BM, et al. Quality performance indicators for oesophageal and gastric cancer: ANZ expert Delphi consensus. ANZ Journal of Surgery. 2024. doi:10.1111/ans.19173
BibTeX
@article{Kulasegaran2024,
author = {Kulasegaran, Suheelan and Woodhouse, Braden and Wang, Yijiao and Siddaiah-Subramanya, Manjunath and Merrett, Neil and Smithers, Bernard Mark and Watson, David and MacCormick, Andrew and Srinivasa, Sanket and Koea, Jonathan},
title = {Quality performance indicators for oesophageal and gastric cancer: ANZ expert Delphi consensus},
journal = {ANZ Journal of Surgery},
year = {2024},
doi = {10.1111/ans.19173}
}
EUVIMED